Kathryn B. Hyer
Directeur/Bestuurslid bij Pier Pharmaceuticals, Inc.
Actieve functies van Kathryn B. Hyer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Pier Pharmaceuticals, Inc.
Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO. | Directeur/Bestuurslid | 03-11-2009 | - |
Loopbaan van Kathryn B. Hyer
Eerdere bekende functies van Kathryn B. Hyer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RESPIRERX PHARMACEUTICALS INC. | Directeur/Bestuurslid | 10-08-2012 | - |
Zevex International, Inc.
Zevex International, Inc. Electronic Equipment/InstrumentsElectronic Technology Zevex International, Inc. manufactures, designs and distributes medical devices. It distributes portable & stationary pumps and disposable sets that are used in the delivery of enteral nutrition for patients in homes, hospitals, and nursing homes. Its products include diagnostic & therapeutic systems, optoelectronic devices, ultrasonic sensors, and surgical handpieces. The company was founded in 1986 by David J. Mcnally and Phillip L. McStotts and is located in Salt Lake City, UT. | Corporate Officer/Principal | - | - |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Financieel Directeur/CFO | - | - |
Everen Securities, Inc. | Oprichter | - | - |
Diagnostic Photonics, Inc.
Diagnostic Photonics, Inc. Medical SpecialtiesHealth Technology Diagnostic Photonics, Inc. develops imaging technology for intra-operative use in clinical settings. It product The Foresee Imaging System places a live view of tissue microstructure at the physician's fingertips, providing immediate insight into tissue microstructure. The company was founded by Stephen Boppart and P. Scott Carney in 2008 and is headquartered in Chicago, IL. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | 18-03-2011 | - | |
Corporate Officer/Principal | - | - | |
Illinois Ventures LLC
Illinois Ventures LLC Investment ManagersFinance Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois. | Private Equity Investor | 01-01-2002 | - |
Opleiding van Kathryn B. Hyer
Aquinas College (Michigan) | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Operationeel
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Private Equity Investor | 1 |
Sectoraal
Health Technology | 5 |
Finance | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RESPIRERX PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Illinois Ventures LLC
Illinois Ventures LLC Investment ManagersFinance Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois. | Finance |
Pier Pharmaceuticals, Inc.
Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Pier Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company which develops a pharmacologic treatment for obstructive sleep apnea (OSA). It develops Dronabinol a synthetic derivative of the naturally occurring substance in the cannabis plant, namely delta-9-tetrahydrocannabinol, otherwise known as delta-9 THC. The company was founded in 2007 and is headquartered in Louiseville, CO. | Health Technology |
Diagnostic Photonics, Inc.
Diagnostic Photonics, Inc. Medical SpecialtiesHealth Technology Diagnostic Photonics, Inc. develops imaging technology for intra-operative use in clinical settings. It product The Foresee Imaging System places a live view of tissue microstructure at the physician's fingertips, providing immediate insight into tissue microstructure. The company was founded by Stephen Boppart and P. Scott Carney in 2008 and is headquartered in Chicago, IL. | Health Technology |
Everen Securities, Inc. | Finance |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
Zevex International, Inc.
Zevex International, Inc. Electronic Equipment/InstrumentsElectronic Technology Zevex International, Inc. manufactures, designs and distributes medical devices. It distributes portable & stationary pumps and disposable sets that are used in the delivery of enteral nutrition for patients in homes, hospitals, and nursing homes. Its products include diagnostic & therapeutic systems, optoelectronic devices, ultrasonic sensors, and surgical handpieces. The company was founded in 1986 by David J. Mcnally and Phillip L. McStotts and is located in Salt Lake City, UT. | Electronic Technology |
- Beurs
- Insiders
- Kathryn B. Hyer
- Ervaring